Biophysical Journal 71: 2830-2839 (1996)
© 1996 the Biophysical Society

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matthews, J H Articles by Tulinsky, A Search for Related Content PubMed PubMed Citation Articles by Matthews, J H Articles by Tulinsky, A

Crystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding site.

Department of Chemistry, Michigan State University, East Lansing 48824, USA.

ABSTRACT

Structures of the blood clotting enzyme thrombin complexed with hirugen and two active site inhibitors, RWJ-50353 10080(N-methyl-D-phenylalanyl-N-[5-[(aminoiminomethyl)amino]-1- [[(2-benzothiazolyl)carbonyl]butyl]-L-prolinamide trifluoroacetate hydrate) and RWJ-50215 (N-[4-(aminoiminomethyl)amino-1-[2- (thiazol-2-ylcarbonylethyl)piperidin- 1-ylcarbonyl]butyl]-5-(dimethylamino)naphthalenesulfonamide trifluoroacetate hydrate), were determined by x-ray crystallography. The refinements converged at R values of 0.158 in the 7.0-2.3-A range for RWJ-50353 and 0.155 in the 7.0-1.8-A range for RWJ-50215. Interactions between the protein and the thiazole rings of the two inhibitors provide new valuable information about the S1' binding site of thrombin. The RWJ-50353 inhibitor consists of an S1'-binding benzothiazole group linked to the D-Phe-Pro-Arg chloromethyl ketone motif. Interactions with the S1-S3 sites are similar to the D-phenylalanyl-prolyl-arginyl chloromethylketone structure. In RWJ-50215, a S1'-binding 2-ketothiazole group was added to the thrombin inhibitor-like framework of dansylarginine N-(3-ethyl-1,5-pentanediyl)amide. The geometry at the S1-S3 sites here is also similar to that of the parent compound. The benzothiazole and 2-ketothiazole groups bind in a cavity surrounded by His57, Tyr60A, Trp60D, and Lys60F. This location of the S1' binding site is consistent with previous structures of thrombin complexes with hirulog-3, CVS-995, and hirutonin-2 and -6. The ring nitrogen of the RWJ-50353 benzothiazole forms a hydrogen bond with His57, and Lys60F reorients because of close contacts. The oxygen and nitrogen of the ketothiazole of RWJ-50215 hydrogen bond with the NZ atom of Lys60F.

This article has been cited by other articles:

				K. Kamata, H. Kawamoto, T. Honma, T. Iwama, and S.-H. Kim Structural basis for chemical inhibition of human blood coagulation factor Xa PNAS, June 9, 1998; 95(12): 6630 - 6635. [Abstract] [Full Text] [PDF]

				R. Morenweiser, E. A. Auerswald, A. van de Locht, H. Fritz, J. Sturzebecher, and M. T. Stubbs Structure-based Design of a Potent Chimeric Thrombin Inhibitor J. Biol. Chem., August 8, 1997; 272(32): 19938 - 19942. [Abstract] [Full Text] [PDF]